Xinjiang will be the new crown pneumonia drug Azulfidine tablets sunshine network and temporary inclusion of medical insurance settlement

Read Time:2 Minute, 54 Second

In the evening of 22, Xinjiang held a press conference on the prevention and control of the epidemic. Xinjiang Medical Security Bureau level one inspector Han Cheng informed the Xinjiang medical insurance department to do a good job in the work of medical insurance services.

Han Cheng said, after the current round of the epidemic, Xinjiang Medical Security Bureau to the region’s designated treatment medical institutions advance funds 37.55 million yuan, timely new crown pneumonia drug Azulfidine tablets sunshine network, and temporarily into the medical insurance settlement, to effectively relieve medical institutions patient treatment and epidemic prevention and control of funds advance pressure, to ensure that patients do not affect the cost of medical treatment, to ensure that the receiving hospital does not affect treatment due to payment policy.

In the implementation of the levy reduction and deferral policy. He said the health insurance sector to ensure that small and medium-sized enterprises do not affect the normal health insurance entitlements of participants due to payment policies. The implementation of tax reduction and fee reduction policy will reduce the unit contribution rate of basic medical insurance for employees from 9% to 7.5% in seven co-ordinated areas (autonomous region level, Urumqi, Ili Prefecture, Tacheng Prefecture, Bo Prefecture, Changji Prefecture and Kechu Prefecture), with the reduction tentatively scheduled from March 2022 to February 2023. By the end of August, a total of 1.312 billion yuan has been reduced in health insurance premiums, benefiting 108,500 units (enterprises).

In addition, starting from July 2022, the payment of 3 months of unit contributions for basic health insurance for small and medium-sized enterprises and individual businesses insured as a unit will be suspended, and the late payment fee will be waived during the suspension period, and the “no application, no access” mode of operation will be fully implemented to ensure that participants will enjoy all the benefits during the suspension period. As of August 31, 86,400 small and medium-sized enterprises in the region enjoy the deferred payment policy, deferred payment amounting to 351 million yuan.

Han Cheng said that Xinjiang also implemented “online”, “convenient”, “postponed” and other services. From August 1 to September 21, a total of 3.087 billion yuan of medical insurance fees were settled and paid to designated medical institutions; 10,116 people were registered for cross-province medical treatment; information maintenance of participants, medical insurance transfer and other medical insurance services were handled. The number of participants’ information maintenance, medical insurance relationship transfer and other medical insurance services was 244,600 (times).

In terms of “people-friendly”, Han Cheng said, at present, the region provides 465 pharmacies for outpatient special chronic diseases, including 70 new ones; 14 regions (states and cities) have opened 5 outpatient special chronic diseases such as hypertension, diabetes, outpatient radiotherapy for malignant tumors, dialysis for uremia, and anti-rejection treatment after organ transplantation. The direct settlement service for foreign medical treatment; opening green channels for outpatient special chronic diseases (malignant tumor, renal failure, organ transplantation).

“The medical insurance department also implemented the ‘extension to do’, extend the validity of the medical expenses manual (sporadic) reimbursement business, 2022 manual (sporadic) reimbursement of medical expenses declaration time can be extended by 6 months, the participating units, the participants can be effective control of the epidemic before going to the Medical Security Bureau office The lobby for manual (sporadic) reimbursement business to ensure that the participants enjoy their treatment.” Han Cheng said. (End)